AstraZeneca drug selumetinib fails in uveal mela**ma trial
 

AstraZeneca drug selumetinib fails in uveal mela**ma trial
LONDON, July 22 (Reuters) - AstraZeneca's much anticipated cancer drug pipeline suffered a blow on Wednesday when the experimental drug selumetinib failed to meet its goal in a late-stage trial for uveal mela**ma.


http://rc.feedsportal.com/r/23456588...21/rc/1/rc.img

http://rc.feedsportal.com/r/23456588...21/rc/2/rc.img

http://rc.feedsportal.com/r/23456588...21/rc/3/rc.img

http://da.feedsportal.com/r/23456588...a/sc/21/a2.img
http://adchoice.feedsportal.com/r/23.../sc/21/ach.imghttp://pi.feedsportal.com/r/23456588.../sc/21/a2t.imghttp://pi2.feedsportal.com/r/2345658...sc/21/a2t2.imghttp://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...JE:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...JE:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/Y6XPDeIbrhM